NOVEL PYRIMIDINE COMPOUND HAVING BENZYL(PYRIDYLMETHYL)AMINE STRUCTURE AND PHARMACEUTICAL COMPRISING THE COMPOUND
申请人:Kowa Company. Ltd.
公开号:EP2055703A1
公开(公告)日:2009-05-06
A compound represented by the following general formula (I) or a salt thereof, or a solvate thereof
(wherein R1, R2, R3, R4 and R5 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group etc., R6, R7 and R8 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group etc., R9 and R10 are the same or different, and represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group etc., and R11 represents hydrogen atom, a halogen atom, a lower alkoxy group, a (lower alkyl)thio(lower alkoxy) group, a (lower alkyl)sulfinyl(lower alkoxy) group, a (lower alkyl)sulfonyl(lower alkoxy) group etc.), which has potent inhibitory activity on CETP.
由以下通式(I)代表的化合物或其盐或其溶液
(其中 R1、R2、R3、R4 和 R5 相同或不同,代表氢原子、卤素原子、低级烷基等;R6、R7 和 R8 相同或不同,代表氢原子、卤素原子、低级烷基等;R9 和 R10 相同或不同,代表氢原子、低级烷基、(低级环烷基)(低级烷基)基团等、以及 R11 代表氢原子、卤素原子、低级烷氧基、(低级烷基)硫(低级烷氧基)基团、(低级烷基)亚磺酰(低级烷氧基)基团、(低级烷基)磺酰(低级烷氧基)基团等),对 CETP 具有强效抑制活性。